Menu

Question 701

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with pain in her distal radius. Imaging reveals an eccentric, lytic epiphyseal lesion. Biopsy shows characteristic multinucleated giant cells.

Which targeted biologic therapy is FDA-approved for unresectable or recurrent cases of this specific bone tumor?

. Imatinib
. Denosumab
. Rituximab
. Doxorubicin
. Methotrexate

Correct Answer & Explanation

. Denosumab


Explanation

The presentation and histology describe a Giant Cell Tumor (GCT) of bone. The neoplastic stromal cells in GCT express high levels of RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells). Denosumab is a monoclonal antibody against RANKL and is an effective targeted therapy for locally advanced, unresectable, or recurrent GCTs.

Question 702

Topic: Biology, Genetics & Bone Healing

A 30-year-old female undergoes biopsy of an eccentric, lytic lesion in the distal femoral epiphysis. Histology reveals numerous multinucleated giant cells in a background of mononuclear stromal cells. She is initiated on denosumab therapy prior to planned surgical intervention. What is the specific mechanism of action of denosumab in treating this lesion?

. It binds to the RANK receptor on osteoclasts, preventing activation.
. It binds directly to RANKL, preventing it from interacting with RANK on osteoclasts.
. It serves as a recombinant analog of osteoprotegerin (OPG), directly destroying neoplastic cells.
. It inhibits Vascular Endothelial Growth Factor (VEGF), leading to tumor necrosis.
. It induces apoptosis primarily in the multinucleated giant cells.

Correct Answer & Explanation

. It binds directly to RANKL, preventing it from interacting with RANK on osteoclasts.


Explanation

Giant cell tumor of bone (GCTB) is characterized by neoplastic mononuclear stromal cells that express high levels of Receptor Activator of Nuclear Factor Kappa-B Ligand (RANKL). This RANKL binds to the RANK receptor on osteoclast precursors, leading to the recruitment of the numerous, non-neoplastic multinucleated giant cells that cause massive bone resorption. Denosumab is a humanized monoclonal antibody that binds directly to RANKL (not the RANK receptor), preventing it from binding to RANK, thereby inhibiting osteoclast-mediated bone destruction.

Question 703

Topic: Biology, Genetics & Bone Healing
A 35-year-old male is recovering from a closed diaphyseal tibial fracture treated with a cast. Secondary bone healing is occurring via endochondral ossification, progressing through the soft callus stage. Which of the following is the predominant collagen type synthesized in the soft callus phase of fracture healing?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IV collagen
. Type X collagen

Correct Answer & Explanation

. Type II collagen


Explanation

Secondary bone healing involves formation of a callus. The soft callus phase is characterized by the formation of cartilaginous tissue bridging the fracture site, which stabilizes the fracture and acts as a scaffold. Because this tissue is essentially fibrocartilage and hyaline cartilage, Type II collagen is the predominant collagen type. Type X collagen is produced later by hypertrophic chondrocytes during endochondral ossification. Type I collagen predominates in mature bone (the hard callus phase).

Question 704

Topic: Biology, Genetics & Bone Healing

A 68-year-old female presents with atraumatic thigh pain. She has been taking oral alendronate for 8 years. Radiographs reveal cortical thickening of the lateral cortex of the subtrochanteric femur and a transverse fracture.

Which of the following best describes the pathomechanism of this injury?

. Overactivity of osteoblasts
. Accumulation of microdamage due to suppressed targeted remodeling
. Inadequate mineralization of osteoid
. Increased osteoclastic resorption leading to weakened woven bone
. Mutation in COL1A1 gene

Correct Answer & Explanation

. Accumulation of microdamage due to suppressed targeted remodeling


Explanation

Bisphosphonates are potent inhibitors of osteoclast-mediated bone resorption. Long-term use severely suppresses bone turnover, preventing the targeted remodeling of normal microdamage. This accumulation of microdamage leads to atypical femoral fractures, classically presenting with lateral cortical thickening and a transverse or short oblique fracture pattern.

Question 705

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of fracture healing, which type of tissue is expected to form within a fracture gap if the mechanical strain environment is maintained between 2% and 10%?

. Primary osteonal bone
. Granulation tissue
. Hyaline cartilage
. Lamellar bone
. Woven bone and cartilage (Callus)

Correct Answer & Explanation

. Woven bone and cartilage (Callus)


Explanation

Perren's strain theory dictates the type of tissue that can survive and differentiate in a fracture gap based on deformation (strain).- Strain < 2%: Allows for primary bone healing (lamellar bone formation) without a callus.- Strain between 2% and 10%: Tolerated by cartilage and woven bone, leading to secondary bone healing via endochondral ossification (callus formation).- Strain > 10%: Tissues tear, and only granulation tissue can survive, leading to nonunion if not stabilized.

Question 706

Topic: Biology, Genetics & Bone Healing

A 30-year-old female is diagnosed with a biopsy-proven giant cell tumor of the distal radius. Due to the extent of the lesion, she is treated with denosumab preoperatively. What is the precise mechanism of action of this pharmacological agent?

. It directly binds to and inhibits the RANK receptor on the surface of osteoclasts
. It binds to and inhibits the RANKL protein, preventing osteoclast formation and activation
. It induces targeted apoptosis of the neoplastic stromal cells through the p53 pathway
. It blocks the VEGF pathway to decrease tumor neoangiogenesis
. It acts as a synthetic analog of osteoprotegerin (OPG) produced by osteoblasts

Correct Answer & Explanation

. It binds to and inhibits the RANKL protein, preventing osteoclast formation and activation


Explanation

Denosumab is a fully human monoclonal antibody that binds to Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). Giant cell tumors of bone consist of neoplastic mononuclear stromal cells that overexpress RANKL, which in turn recruits and hyperactivates multinucleated giant cells (osteoclast-like cells) expressing the RANK receptor. By binding RANKL, denosumab prevents it from interacting with RANK on osteoclasts, severely halting bone resorption and leading to ossification of the tumor matrix.

Question 707

Topic: Biology, Genetics & Bone Healing

Which of the following transcription factors most strongly promotes the differentiation of mesenchymal stem cells into osteoblasts during fracture healing?

. Low oxygen tension
. High strain environment
. Core binding factor alpha-1 (Runx2)
. Sclerostin
. Tumor necrosis factor-alpha

Correct Answer & Explanation

. Core binding factor alpha-1 (Runx2)


Explanation

Core binding factor alpha-1 (Cbfa1), also known as Runx2, is the master transcription factor responsible for the differentiation of multipotent mesenchymal stem cells into the osteoblast lineage. Sclerostin is a Wnt antagonist that inhibits bone formation. High strain promotes fibrous tissue, and low oxygen promotes cartilage formation.

Question 708

Topic: Biology, Genetics & Bone Healing
In the process of endochondral ossification during fracture healing, which type of collagen is most predominantly synthesized by chondrocytes in the hypertrophic zone just prior to calcification?
. Type I collagen
. Type II collagen
. Type III collagen
. Type IX collagen
. Type X collagen

Correct Answer & Explanation

. Type X collagen


Explanation

Hypertrophic chondrocytes uniquely synthesize Type X collagen during endochondral ossification. This collagen plays a critical role in the mineralization of the cartilaginous matrix, allowing subsequent vascular invasion and replacement by bone.

Question 709

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction and are utilized in various spine and trauma applications.

Which of the following intracellular signaling molecules is directly phosphorylated following the binding of BMP-2 or BMP-7 to its serine/threonine kinase membrane receptor?

. Beta-catenin
. Smad 1/5/8
. Smad 2/3
. Smad 4
. Runx2

Correct Answer & Explanation

. Smad 1/5/8


Explanation

BMPs exert their effects by binding to specific serine/threonine kinase receptors on the cell surface. This binding leads to the direct phosphorylation of the receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These then form a complex with the common-mediator Smad 4, which translocates to the nucleus to upregulate osteogenic genes like Runx2. TGF-beta, in contrast, signals via Smad 2 and 3.

Question 710

Topic: Biology, Genetics & Bone Healing

A 30-year-old woman presents with worsening knee pain. Radiographs reveal an eccentric, lytic, expansile lesion located in the epiphysis of the proximal tibia, extending to the subchondral bone. There is no sclerotic margin. Histology demonstrates mononuclear cells and numerous uniformly distributed osteoclast-like multinucleated giant cells. Which of the following is the most effective targeted medical therapy for advanced, unresectable cases of this tumor?

. Imatinib
. Denosumab
. Methotrexate
. Doxorubicin
. Rituximab

Correct Answer & Explanation

. Denosumab


Explanation

The clinical and radiographic presentation is classic for a Giant Cell Tumor of Bone (GCTB). The neoplastic mononuclear cells in GCTB express high levels of RANKL, which recruits and activates the osteoclast-like giant cells, leading to massive bone destruction. Denosumab, a monoclonal antibody against RANKL, is highly effective in treating GCTB and is used for unresectable or recurrent lesions, or as a neoadjuvant therapy.

Question 711

Topic: Biology, Genetics & Bone Healing

Demineralized bone matrix (DBM) is commonly used as a bone graft extender in spinal fusion surgery. Which of the following correctly describes the biologic properties of DBM?

. Osteogenic, osteoinductive, and osteoconductive
. Osteoinductive and osteoconductive only
. Osteoconductive only
. Osteogenic and osteoconductive only
. Osteoinductive only

Correct Answer & Explanation

. Osteoinductive and osteoconductive only


Explanation

Demineralized bone matrix (DBM) is processed allograft bone that has had the inorganic mineral component removed, leaving the organic collagen matrix and growth factors (such as bone morphogenetic proteins, BMPs). It is osteoinductive (due to the presence of BMPs) and osteoconductive (providing a biologic scaffold). It is not osteogenic because the processing destroys living cells (osteoblasts or osteoprogenitor cells).

Question 712

Topic: Biology, Genetics & Bone Healing

Denosumab is widely utilized as a neoadjuvant or definitive therapy for unresectable Giant Cell Tumor of Bone. By what mechanism does denosumab arrest the progression of this lesion?

. It induces apoptosis of the neoplastic mononuclear stromal cells directly via p53 activation
. It cross-links DNA via alkylation, preventing mitosis in highly proliferative cells
. It competitively inhibits vascular endothelial growth factor (VEGF), leading to tumor ischemia
. It stimulates osteoblastic activity by agonizing the Wnt/beta-catenin pathway
. It acts as a monoclonal antibody against RANKL, preventing osteoclast-like giant cell formation

Correct Answer & Explanation

. It acts as a monoclonal antibody against RANKL, preventing osteoclast-like giant cell formation


Explanation

Giant Cell Tumor of Bone consists of neoplastic mononuclear stromal cells that overexpress RANKL (Receptor Activator of Nuclear factor Kappa-B Ligand). This overproduction recruits and activates reactive multinucleated osteoclast-like giant cells, which cause massive localized bone destruction. Denosumab is a fully human monoclonal antibody that binds directly to RANKL, inhibiting the formation, function, and survival of these giant cells, thereby arresting osteolysis and allowing the bone to re-ossify.

Question 713

Topic: Biology, Genetics & Bone Healing

A 28-year-old male presents with knee pain. Radiographs reveal an eccentric, purely lytic epiphyseal lesion extending to the subchondral bone of the proximal tibia. Biopsy histology is shown.

Multinucleated giant cells in a background of mononuclear stromal cells are seen. Which systemic medication is specifically designed to target the pathophysiology of this lesion?

. Methotrexate
. Doxorubicin
. Imatinib
. Denosumab
. Bisphosphonates

Correct Answer & Explanation

. Denosumab


Explanation

The patient has a Giant Cell Tumor (GCT) of bone. The neoplastic mononuclear stromal cells in GCT express high levels of RANKL, which stimulates the recruitment and differentiation of non-neoplastic multinucleated giant cells that cause the osteolysis. Denosumab is a monoclonal antibody that inhibits RANKL, effectively halting this process and promoting ossification of the lytic defect. It is utilized for unresectable tumors or to facilitate joint salvage.

Question 714

Topic: Biology, Genetics & Bone Healing

A 32-year-old female presents with progressive knee pain. Imaging reveals an eccentric, lytic epiphyseal-metaphyseal lesion of the distal femur. A biopsy demonstrates multinucleated giant cells in a background of mononuclear stromal cells.

If neoadjuvant medical therapy is utilized prior to curettage, the mechanism of action of the most appropriate drug is:

. Direct cytotoxicity targeting multinucleated giant cells
. Inhibition of osteoclast proton pumps
. Inhibition of RANK ligand (RANKL)
. Inhibition of Vascular Endothelial Growth Factor (VEGF)
. Downregulation of parathyroid hormone receptors

Correct Answer & Explanation

. Inhibition of RANK ligand (RANKL)


Explanation

The diagnosis is Giant Cell Tumor (GCT) of bone. Denosumab is a monoclonal antibody often used in the medical management of GCT. Its mechanism of action is the inhibition of RANK ligand (RANKL). In GCT, the neoplastic cells are the mononuclear stromal cells, which express RANKL. This recruits and activates the non-neoplastic, multinucleated osteoclast-like giant cells that cause the massive bone resorption.

Question 715

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory regarding fracture healing, what biological response is observed when the interfragmentary strain at a fracture site is between 2% and 10%?

. Primary bone healing via cutting cones
. Resorption of the fracture ends without callus formation
. Callus formation and secondary bone healing
. Granulation tissue formation followed by persistent nonunion
. Woven bone formation directly converting to lamellar bone without intermediate tissues

Correct Answer & Explanation

. Callus formation and secondary bone healing


Explanation

Perren's strain theory states that the type of tissue that forms at a fracture site is dependent on the strain. Absolute stability (<2% strain) allows for primary bone healing (cutting cones) without callus. Relative stability (2-10% strain) stimulates callus formation (secondary bone healing). Strain greater than 10-15% leads to the formation of fibrous or granulation tissue, ultimately resulting in a nonunion if the strain is not reduced.

Question 716

Topic: Biology, Genetics & Bone Healing

Articular cartilage is structurally organized into distinct zones. Which zone is specifically adapted to resist the highest shear forces and is characterized by a dense concentration of collagen fibers oriented parallel to the articular surface?

. Superficial (tangential) zone
. Middle (transitional) zone
. Deep (radial) zone
. Tidemark
. Calcified cartilage zone

Correct Answer & Explanation

. Superficial (tangential) zone


Explanation

The superficial (tangential) zone of articular cartilage comprises the top 10-20% of articular cartilage. It has a high concentration of densely packed collagen type II fibers that are aligned parallel to the joint surface. This specific structural orientation provides the highest tensile strength and the greatest resistance to shear forces within the joint.

Question 717

Topic: Biology, Genetics & Bone Healing

A 30-year-old female is diagnosed with an expansile, lytic lesion in her distal femur that extends to the subchondral bone. Biopsy confirms a Giant Cell Tumor (GCT) of bone. She is treated preoperatively with denosumab.

What is the molecular target of denosumab in the treatment of this tumor?

. The RANK receptor on the surface of osteoclast precursors
. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL) secreted by neoplastic stromal cells
. Osteoprotegerin (OPG)
. Vascular Endothelial Growth Factor (VEGF)
. Matrix Metalloproteinases (MMPs)

Correct Answer & Explanation

. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL) secreted by neoplastic stromal cells


Explanation

In a Giant Cell Tumor of bone, the actual neoplastic cells are the mononuclear spindle-like stromal cells. These cells secrete excessive amounts of RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclasts) that cause bone destruction. Denosumab is a monoclonal antibody that specifically targets and binds to RANKL, preventing it from interacting with the RANK receptor on osteoclast precursors, thereby halting bone lysis.

Question 718

Topic: Biology, Genetics & Bone Healing

Which of the following statements most accurately describes the mechanism and requirements of primary (direct) bone healing?

. It occurs via endochondral ossification and a robust cartilage intermediate.
. It requires absolute stability and occurs via cutting cones crossing the fracture site.
. It relies on controlled micromotion to stimulate abundant bridging callus formation.
. It proceeds primarily through intramembranous ossification mediated solely by the periosteum.
. It is the typical mode of healing seen with intramedullary nailing of comminuted diaphyseal fractures.

Correct Answer & Explanation

. It requires absolute stability and occurs via cutting cones crossing the fracture site.


Explanation

Primary (direct) bone healing occurs without a cartilage intermediate and without the formation of a visible callus. It requires absolute stability (rigid fixation with no micromotion, such as with compression plating) and intimate bone contact. The mechanism involves osteoclastic cutting cones that cross the fracture line, immediately followed by osteoblasts laying down new osteons (Haversian remodeling).

Question 719

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) initiate intracellular signaling primarily by binding to transmembrane serine/threonine kinase receptors that directly phosphorylate and activate which of the following downstream mediators?

. Wnt/beta-catenin complex
. Smad proteins
. JAK/STAT pathway
. RANK/RANKL complex
. Notch receptors

Correct Answer & Explanation

. Smad proteins


Explanation

BMPs bind to types I and II serine/threonine kinase receptors. Upon activation, they phosphorylate receptor-regulated Smads (R-Smads 1, 5, and 8), which then bind to the common-partner Smad (Co-Smad 4) to translocate to the nucleus and regulate the transcription of osteogenic target genes.

Question 720

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, the type of tissue that forms in a fracture gap is dictated by the mechanical strain environment. What is the maximum tissue strain limit that allows for the formation of lamellar bone?

. < 2%
. 2% - 10%
. 10% - 30%
. 30% - 50%
. > 50%

Correct Answer & Explanation

. < 2%


Explanation

Perren's strain theory states that lamellar bone can only form in low strain environments (< 2% strain). Woven bone tolerates up to 10% strain, fibrocartilage tolerates 10-30%, and granulation tissue can tolerate up to 100% strain before failing.